Skip to content

A Global Mapping of Access and Benefit Sharing (ABS) Frameworks

A Global Mapping of Access and Benefit Sharing (ABS) Frameworks
Image Credit: Pexels, kdadan
Published:

Newsletter Edition #385

[GHF Plus: Global Health Policy Intelligence]


Readers,

In this edition, we bring you a mapping of laws on Access and Benefit Sharing across the world. Here is what you will find:

  • A comparative assessment of 201 countries and jurisdictions on existence, scope, and key characteristics of their Access and Benefit Sharing (ABS) frameworks
  • A mapping of how many countries recognize the importance of protecting both biological resources and indigenous or local community knowledge
  • How many countries have Digital Sequence Information subject to ABS obligations.
  • How much is the access to genetic resources regulated.
  • To what extent is Prior Informed Consent a key operational mechanism among countries implementing ABS frameworks.
  • A picture on compliance, sanctions and legal enforcements
  • How many jurisdictions link access permissions to benefit sharing arrangements.
  • And key takeaways for the negotiations on Pathogen Access and Benefit Sharing System

My colleague Khushi Makwana, an India-based lawyer, has put this together for our subscribers. She has been a part of our annual fellowship program.

This is a premium offering under GHF Plus, a global health intelligence product for our core supporters. We announced this last year and have since served up research reports and other tools every quarter. You will find previous GHF Plus products at the end of this edition when you scroll below, and in our archives.

Learn more about the various tiers of subscriptions we offer. GHF Basic is for all our paying subscribers. GHF Plus is a higher tier for our core supporters. If you want to consider upgrading to access our premium products, please drop me a line. Alternatively, one can also upgrade from an existing paid subscription to this tier.

Also, we are keen on providing value to our readership of global health experts. If you have specific ideas and projects you'd like us to work on, please let us know by simply replying to this email. We will give it our utmost consideration.


Geneva Health Files offers value to our readers who are experts in global health. Tracking global health policy-making in Geneva is tough and expensive, without institutional support. For six years, we have provided you with the information and tools that directly contribute to your work in the field. We rely on our readers who value news they can use.

By becoming a paying subscriber you make our work possible and help us gather, report and synthesise global health intelligence.


Thanks!

Priti Patnaik, Founder & Publisher, Geneva Health Files

Feel free to write to us: genevahealthfiles@gmail.com ; Find us on BlueSky, Instagram and Linkedin

Geneva Health Files
If You Work in Global Health, You Cannot Do Without Reading Us

A GHF PLUS OFFERING

A Global Mapping of Access and Benefit Sharing (ABS) Frameworks

By Khushi Makwana

Julia Dötzer & Priti Patnaik contributed to this project

Makwana is a legal and healthcare management professional with a focus on healthcare policy, compliance, and systems improvement. She can be reached at officekhushimakwana@gmail.com. 


This database provides a comparative assessment of 201 countries and jurisdictions on existence, scope, and key characteristics of their Access and Benefit Sharing (ABS) frameworks, with a particular focus on provisions relevant to genetic resources, microorganisms, traditional knowledge, Digital Sequence Information (DSI), access requirements, benefit sharing, compliance mechanisms, and legal sanctions.

Overall Status of ABS Frameworks

Of the 201 countries assessed:

  • 66 countries have reported an ABS framework through the Access and Benefit Sharing Clearing House (ABSCH).
  • 96 countries have no identified ABS legislation or framework.
  • 39 countries have limited, unclear, developing, or unverified ABS status where a definitive ABSCH reporting status could not be confirmed.

The findings demonstrate that while ABS implementation has expanded significantly since the adoption of the Convention on Biological Diversity and the Nagoya Protocol, global implementation remains uneven.

From our partners